Results 241 to 250 of about 9,613,246 (402)
An Atypical Presentation of Thyroid Eye Disease in a Patient With a Remote History of Graves' Disease. [PDF]
Van Buren NL, Yu CY, Bradley EA.
europepmc +1 more source
Graves’ disease and mental disorders
A. Fukao+7 more
semanticscholar +1 more source
The co‐delivery of mRNAs encoding a CD47 inhibitor and a cytokine cocktail (interleukins 12, 15, and 21) via lipid nanoparticles enables effective localized immunotherapy. This strategy not only suppresses tumor progression but also enhances type 1 conventional dendritic cell (cDC1) differentiation and activates CD8+ T cells, thereby inducing robust ...
Tao Jiang+14 more
wiley +1 more source
Oscillation between Hyperthyroidism and Hypothyroidism in an Adolescent Female with Graves' Disease. [PDF]
Lee YL.
europepmc +1 more source
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li+11 more
wiley +1 more source
Rare Autoimmune Pancytopenia Due to Graves Disease. [PDF]
Wang AW, Mahajan G, Etra A, Saul SR.
europepmc +1 more source
In pancreatic ductal adenocarcinoma (PDAC), tumor‐intrinsic PD‐1 signaling activates the MET pathway, leading to the establishment of an immunosuppressive tumor microenvironment (TME). This MET‐driven signaling cascade promotes the selective accumulation of GITR+ regulatory T cells (Tregs), a highly immunosuppressive subset.
Jiande Han+16 more
wiley +1 more source
Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review. [PDF]
Viola N+5 more
europepmc +1 more source
On the specific attitude of I131 uptake of thyroid in the thyroid functiontests of Graves' disease
Tomio TOMONAGA
openalex +2 more sources